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AbstrACt
Objectives Hearing loss is an area of unmet need, and 
industry is targeting this field with a growing range of 
surgically implanted hearing devices. Currently, there 
is no comprehensive UK registry capturing data on 
these devices; in its absence, it is difficult to monitor 
clinical and cost-effectiveness and develop national 
policy. Recognising that developing such a registry faces 
considerable challenges, it is important to gather opinions 
from stakeholders and patients. This paper builds on our 
systematic review on surgical registry development and 
aims to identify the specific requirements for developing a 
successful national registry of auditory implants.
Design Qualitative study.
Participants Data were collected in two ways: 
(1) semistructured interviews with UK professional 
stakeholders; and (2) focus groups with patients with 
hearing loss. The interview and focus group schedules 
were informed by our systematic review on registry 
development. Data were analysed using directed content 
analysis. Judges mapped the themes obtained against 
a conceptual framework developed from our systematic 
review on registry development. The conceptual 
framework consisted of five categories for successful 
registry development: (1) planning, (2) registry governance, 
(3) registry dataset, (4) anticipating challenges, (5) 
implementing solutions.
results Twenty-seven themes emerged from 
40 semistructured interviews with professional 
stakeholders and 18 themes emerged from three 
patient focus groups. The most important factor for 
registry success was high rates of data completion. 
Benefits of developing a successful registry of auditory 
implants include: strengthening the evidence base and 
regulation of auditory implants, driving quality and safety 
improvements, increased transparency, facilitating patient 
decision-making and informing policy and guidelines 
development.
Conclusions This study identifies the requirements for 
developing a successful national registry of auditory 
implants, benefiting from the involvement of numerous 
professional stakeholder groups and patients with hearing 
loss. Our approach may be used internationally to inform 
successful registry development.
IntrODuCtIOn 
Hearing loss has been identified as a key 
public priority by the Department of Health 
(DoH) and UK policy-makers.1–3 In the UK, 
10 million people suffer from hearing loss, 
with an estimated annual cost to the economy 
of £30 billion.1 4 Hearing loss has a major 
impact on social functioning and is associ-
ated with an increased risk of dementia.1 5–11 
Importantly, the impacts of hearing loss are 
set to increase with our ageing population.8 9 
Policy-makers, guideline developers, clini-
cians, researchers and industry have real-
ised that hearing loss is an area of unmet 
need.1 7 This has resulted in increased 
investment in the development of surgi-
cally implanted hearing devices including 
cochlear implants (CIs), bone conducting 
hearing devices and middle ear implants.
While auditory implants have been widely 
adopted, UK registry data on patients with 
auditory implants are lacking.2 12–14 Safety 
incidents around other surgical implants such 
strengths and limitations of this study
 ► This study adopted an inclusive and robust ap-
proach, involving multiple professional stakeholder 
groups and patients with hearing loss.
 ► Our findings built on a conceptual framework on 
successful surgical registry development, that was 
developed following our systematic review and nar-
rative synthesis.
 ► The interview schedules were informed by our pub-
lished systematic literature review and were piloted 
and updated before data collection.
 ► Interview and focus group data were extracted and 
analysed by two independent data judges, with fur-
ther verification by a data auditor.
 ► We recognise that the use of purposive sampling for 
identifying professional stakeholders may have been 
prone to researcher bias.
 o
n
 28 Septem
ber 2018 by guest. Protected by copyright.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2018-021720 on 12 September 2018. Downloaded from 
2 Mandavia R, et al. BMJ Open 2018;8:e021720. doi:10.1136/bmjopen-2018-021720
Open access 
as the ‘poly implant prostheses’ breast implant and the 
‘metal-on-metal’ hip implant highlight the dangers of not 
collecting such information.15–17 Conversely, successful 
registry initiatives such as the National Hip Fracture Data-
base, the National Joint Registry and the National Audit 
Cardiac Surgery registry highlight the benefits of registry 
data.18–20 Hearing stakeholders, policy-makers and 
patients have recognised that, in the absence of registry 
data, it is difficult to regulate auditory implants, monitor 
clinical and cost-effectiveness, and ultimately develop 
appropriate guidelines and policy.2
A potential solution is to develop a national registry of 
all auditory implants.2 Recognising that developing such 
a registry faces considerable challenges, it is important to 
gather opinions from relevant stakeholders and patients 
with hearing loss.21 This paper builds on our recent 
systematic review22 on successful surgical registry devel-
opment and aims to identify the specific requirements 
for developing a successful national registry of auditory 
implants.
MAterIAls AnD MethODs
ethical considerations
To facilitate patient attendance, travel expenses were 
remunerated and gift vouchers were provided.
Data collection
Data were collected in two ways: (1) semistructured 
interviews with professional stakeholders (PSs); and 
(2) focus groups (FGs) with patients with hearing loss. 
The methodological orientation underpinning the 
study was content analysis,23 and the study protocol was 
designed in accordance with the Consolidated criteria 
for Reporting Qualitative research criteria.24
semistructured interviews with Pss
Participants
We adopted a purposive sampling strategy to identify 
individuals who were especially knowledgeable about 
hearing loss and implants.25 Stakeholders were iden-
tified from a network of professionals known to the 
authors and their collaborators. The list of stakeholders 
was cross-checked by two independent individuals 
from separate institutions. At the end of each inter-
view, interviewees were asked to provide contact details 
of stakeholders with relevant experience to our study. 
Stakeholders were approached via email invitation. Data 
analysis commenced after completion of the first inter-
view. Stakeholders were recruited and interviewed until 
data saturation was reached. PS groups were located 
across the UK. Information on stakeholder groups can 
be seen in table 1.
A total of 40 stakeholders were interviewed. This 
sampling approach led to a response rate of 89%. 
Reasons for non-participation included: unable to 
schedule suitable time (n=2) and non-response to invi-
tation (n=3).
Procedures
Individual interviews lasted between 14 and 34 min 
and were digitally recorded and transcribed. Participa-
tion was voluntary, and transcripts were anonymised. 
Participants were interviewed between March 2015 
and December 2016, either in person at the Univer-
sity College London (UCL) Ear Institute or via tele-
phone. The semistructured interviews followed an 
interview schedule comprising 13 questions, each of 
which contained specific probes (see online supple-
mentary appendix 1). The interview schedule was devel-
oped following our narrative systematic review on UK 
surgical registry development.22 The interviewer was an 
ENT Academic Clinical Trainee with expertise in health 
policy research. The interview schedule focused on (1) 
opinions on existing auditory implant registries, (2) the 
requirements of a successful registry and (3) the chal-
lenges of establishing a national registry of auditory 
implants and potential solutions.
The interview schedule was piloted on two professionals 
and updated following their feedback.
FGs with patients with hearing loss
Participants
Adult patients with hearing loss and their family 
members were interviewed in three FGs, each 
comprising 6–7 participants. Participants were iden-
tified from a UCL Ear Institute database of patients 
who had given their consent to take part in clinical 
research. Participants were approached via email invi-
tation. A total of 19 participants were included. Char-
acteristics of participants are shown in table 2. Ten 
patients refused to participate due to: lack of time 
(n=3), caring commitments (n=3) and difficulty in 
travelling (n=4).
Table 1 Stakeholder group frequency
Stakeholder group n
Audiologists 6
ENT surgeons 9
Non-ENT surgical registry representatives 7
ENT registry leads 3
Industry 4
Registry experts 3
Commissioners 2
Patient charity representatives 2
National guidelines experts 3
Policy experts 3
Health economics experts 2
Department of Health representatives 3
National hearing body representatives 4
ENT, ear, nose and throat.
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Procedures
The FGs explored 10 questions, each containing 
specific probes about a future national registry of audi-
tory implants (see online supplementary appendix 2). 
The questions were developed from the same systematic 
review on UK surgical registry development.22 FGs took 
place in July 2016 at the UCL Ear Institute and were 
facilitated by the primary investigator and a patient and 
public involvement expert.
The FG discussions lasted between 90 and 105 min. 
The discussions were recorded using a digital recorder 
and professionally transcribed. Transcripts were anony-
mised. The FG schedule was trialled on two patients and 
updated following their feedback.
Analysis
Data analyses were performed in two stages.
Stage 1: two data judges (RM and CT) qualitatively anal-
ysed the interview and FG transcripts separately using 
directed content analysis.23 Data judges independently 
read through the interview and FG transcripts and 
extracted data from the transcripts manually onto sepa-
rate data extraction tables. The framework of the data 
extraction tables reflected the structure of the interview 
and FG schedules. The data judges independently made 
notes of themes arising from the extracted data and 
compared their analyses. Discrepancies were discussed 
and resolved. Amending the themes list was repeated 
until no new themes emerged. The data judges met 
periodically with the data auditor (AS) to discuss the 
analysis.
Stage 2: Judges independently mapped the themes 
obtained from the stakeholder interviews and FG 
responses against a conceptual framework developed 
from our systematic review on registry development.22 
The conceptual framework consisted of five funda-
mental categories for successful registry development: 
(1) planning, (2) registry governance, (3) registry 
dataset, (4) anticipating challenges, (5) implementing 
solutions.22 Judges compared their findings, and 
discrepancies were discussed and resolved.
Patient involvement
 ► Patients with hearing loss helped inform the research 
question during previous FGs held at the UCL 
institute.
 ► Patients gave feedback on the wording of the FG 
schedule. Their feedback was used to update the 
schedule before carrying out the FG discussions.
 ► Patients were able to suggest the inclusion of their 
family members in the FGs.
 ► Results will be disseminated back to study participants 
during a consensus conference held at the UCL Ear 
Institute.
results
semistructured interviews with Pss
All themes identified are presented below under each 
interview question. A summary of the extracted data 
giving rise each theme is provided. Table 3 summarises 
all themes identified.
PS question (Q) 1: What are your thoughts on the existing auditory 
implant registries available?
Theme (T) 1a: Existing registries available
Stakeholders were aware of the following UK auditory 
registries: the Ear Foundation Bone Anchored Hearing 
Aid registry, The Ear Foundation Bone Conduction 
Hearing Implant (BCHI) registry, Pochia CI registry, 
Bawtry Database, Auditbase, National Audit of Bilateral 
CIs, Auditbase, Otology Web Based database, Cochlear 
Paediatric Implanted Recipient Observational Study 
registry. Some implant centres and device manufactures 
have their own registries.
T1b: Existing registries are limited
Limitations of existing registries include: poor rates 
of data completion; not user-friendly; difficult to navi-
gate and enter data; overly basic or complex datasets; 
Table 2 Characteristics of participants in focus groups
Patient 
number Characteristic Location
1 Family member of patient 
with bilateral hearing aids
Birmingham
2 Unilateral CI user London
3 Family member of patient 
with unilateral CI
London
4 Unilateral CI and unilateral 
hearing aid user
Manchester
5 Family member of patient 
with bilateral hearing aids
Birmingham
6 Bilateral hearing aid user Leeds
7 Unilateral BAHA user London
8 Unilateral CI user Sheffield
9 Bilateral CI user Oxford
10 Bilateral CI user Oxford
11 Member of patient group of 
patients with hearing loss
London
12 Unilateral BAHA user Leicester
13 Unilateral CI user Norwich
14 Unilateral CI user and works 
in a hearing-loss charity
London
15 Unilateral CI and unilateral 
hearing aid user
London
16 Bilateral BAHA user London
17 Unilateral BAHA and 
unilateral hearing aid
Brighton
18 Unilateral CI and unilateral 
BAHA
Reading
19 Bilateral CI user Swindon
CI, cochlear implant, BAHA: bone anchored hearing aid.
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Table 3 Themes identified from stakeholder interviews and patient FGs
Semistructured interviews with PSs
PS Q1. What are your thoughts on the existing auditory 
implant registries available?
T1a. Existing registries 
available
T1b. Existing registries 
are limited
PS Q2. Do you think a national registry of auditory 
implants will be of benefit?
T2a. Improve safety and 
quality of care
T2b. Promote research 
and innovation
T2c. Facilitate 
commissioning 
and guideline 
development
T2d. Help patient 
decision-making
PS Q3. What do you think the main purpose or goal of the 
registry should be?
T3a. To improve the 
quality and safety of 
care
PS Q4. How should the registry be led/who should make 
the decisions?
T4a. Have steering 
committee
PS Q5. How should the registry be managed/maintained? T5a. Dedicated 
management team
T5b. Robust IT systems 
to verify data
PS Q6. Broadly speaking, what do you think should be 
included in the dataset?
T6a. Registry dataset T6b. Quality of life data
PS Q7. What are the main challenges of establishing a 
registry?
T7a. ‘Buy-in’ and data 
completion
T7b. Resource heavy T7c. Registry 
governance
PS Q8. How can we overcome these challenges? T8a. Engage with 
opinion leaders
T8b. Registry 
development and 
design
T8c. Make it 
compulsory
T8d. Make it clearly 
useful
PS Q9. Should patients be involved in the registry and if 
so how?
T9a. Leadership and 
development
T9b. Accessing the 
registry
T9c. Entering data
PS Q10. Who should own the data of the registry? T10a. Independent 
national body
PS Q11. How should we fund the registry? T11a. Multiple sources T11b. Levy on all 
implants used
PS Q12. Should we publish data on specific surgeons 
and hospitals?
T12a. Wait until the 
registry is established
PS Q13. Overall what do you think is the most important 
factor for making a registry successful?
T13a. Data 
completeness
FGs with patients with hearing loss
FG Q1. What are your thoughts on developing a 
registry of patients that have surgically implanted 
hearing devices?
T1a. Improve quality and safety 
of care
T1b. Help develop 
national guidelines and 
policy
T1c. Facilitate 
patient decision-
making
T1d. Challenges 
to registry 
development
FG Q2. How do you think patients could be 
involved in developing, leading or managing such 
a registry?
T2a. Formal patient 
representation
FG Q3. What type of information do you think 
should be recorded in the registry?
T3a. Registry dataset and 
easy-to-understand outcome 
measure
FG Q4. Would you want to be able to access and 
add information into the registry?
T4a. Benefits of patient access T4b. Patients entering 
data
FG Q5. How can we help get patients to input their 
data and be involved in the registry?
T5a. Make the registry useful for 
patients
T5b. Make the registry 
simple and use 
technology
T5c. Inbuilt patient 
discussion forum
FG Q6. Would you like the registry to contain 
information on results of named surgeons or 
hospitals?
T6a. Inaccurate reflection of 
practices
T6b. Increase patient 
choice
FG Q7. How do you think the data should be 
protected and kept confidential? Who should be 
allowed to access your data?
T7a. Data governance T7b. Data protection 
committee
FG Q8. Who should own the data of the registry? T8a. Independent organisation
FG Q9. Registries are expensive to set up and 
maintain. How should the registry be paid for?
T9a. Multiple sources  
FG Q10. Overall, what do you think is the most 
important factor for making a registry successful?
T10a. Data completeness
FG, focus group; IT, information technology; PS, professional stakeholder; Q, questions; T, theme.
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inappropriate outcome measures; too clinician-focused; 
unable to sufficiently inform clinical practice, commis-
sioning or guidelines development.
PS Q2: Do you think a national registry of auditory implants will be 
of benefit?
T2a: improve safety and quality of care
A successful registry would be able to monitor national 
practices, improve quality of care, identify safety 
concerns and facilitate implant recall. The registry 
would also facilitate (inter)national comparison of 
practices and comparison between implants. Poorly 
performing centres could be identified and supported. 
Registry leads noted that their registries were associated 
with improved clinical standards, shorter waiting times 
and length of stay, and reductions in morbidity and 
mortality.
T2b: promote research and innovation
A registry would provide essential data to assess the clin-
ical and cost-effectiveness of auditory implants. It would 
also facilitate research collaborations, provide data with 
external validity, refine indications for implantation and 
drive device improvements and innovations.
T2c: facilitate commissioning and guideline development
A registry would enable monitoring of national clinical 
activity, facilitating efficient implant procurement, fair 
distribution of resources and equitable access to care. 
The registry would also provide valuable information for 
guidelines and policy development.
T2d: help patient decision-making
A national registry would help patients make informed 
decisions by providing them with information on proce-
dure effectiveness and risks.
PS Q3: What do you think the main purpose or goal of the registry 
should be?
T3a: to improve the quality and safety of care
The main purpose of the registry should be to improve 
the quality and safety of care provided while promoting 
transparency and patient choice. The registry should also 
aim to monitor practices and device effectiveness, drive 
clinical research and assist in the development of policy.
PS Q4: How should the registry be led/who should make the 
decisions?
T4a: have a steering committee
The registry should be led by an independent steering 
committee, with representation from: audiologists, an 
ENT UK representative, implant surgeons, commissioners, 
policy experts, a health economist, guideline developers, 
patients and a lay-member. Subcommittees would be 
responsible for separate areas, including funding, data 
collection, data verification and governance.
PS Q5: How should the registry be managed/maintained?
T5a: dedicated management team
The registry should be managed by a dedicated manage-
ment team, responsible for: collecting data centrally, 
maximising data completion and verifying data. Each 
hospital should have its own data manager.
T5b: robust information technology systems to verify data
Robust information technology (IT) systems should be in 
place, to verify and clean data. Registry data can be veri-
fied by comparing it with Hospital Episode Statistics data.
PS Q6: Broadly speaking, what do you think should be included in 
the dataset?
T6a: registry dataset
Table 4 summarises the preoperative, intraoperative and 
postoperative data-items on which consensus was reached. 
Table 4 Stakeholder suggested data-items
Preoperative Operative Postoperative
NHS number/patient identifier (linkable to 
HES)
Name of hospital Length of stay
Patient demographic details Name of operation Hearing test result at each follow-up
Patient diagnosis Date of surgery Complications at each follow-up
Indication Grade of surgeon Employment status
Primary or revision Side of surgery
Cost of implant Surgery start time
Hearing test result Surgical approach
Comorbidities Name, make and model of implant
MDT outcome Implant serial number
Employment status Intraoperative complication(s)
Date of decision to operate Surgery end time
Cost of implant
HES, Hospital Episode Statistics; MDT, multidisciplinary team; NHS, National Health Service.
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A consensus meeting would be required to establish the 
specifics of the dataset.
T6b: quality of life data
Quality of life (QoL) data helps provide meaningful 
outcomes and facilitates health economic analyses. 
However, it is challenging to reach consensus on QoL 
outcome measures, and QoL data collection is time 
consuming and may result in reduced data completion. 
Therefore, QoL data collection should be introduced 
when the registry is well established.
PS Q7: What are the main challenges of establishing a registry?
T7a: ‘buy-in’ and data completion
The main challenge would be achieving long-term ‘buy-
in’ and data completion. Reaching agreement on the 
registry dataset would also be a key challenge.
T7b: resource heavy
The registry would require considerable financial, 
human and time resources for initial set-up, data entry 
and registry maintenance.
T7c: registry governance
Data governance and legal factors are other challenges. 
These include compliance with data protection and 
information governance laws, maintaining data security, 
policing data access, appointing a steering committee, 
identifying data ownership, acquiring patient consent 
and ensuring data accuracy and quality.
PS Q8: How can we overcome these challenges?
T8a: engage with opinion leaders
Having opinion leaders as registry advocates would 
increase registry awareness. Support from influential 
organisations, such as DoH, the National Institute for 
Health and Care Excellence (NICE) and commissioning 
groups, would help maximise registry relevance and 
funding.
T8b: registry development and design
All stakeholder groups should be involved in registry 
development, and the registry must be simple, elec-
tronic and adaptable to maximise data completion 
and promote longevity. A minimal dataset should be 
employed that is quick to complete, with no free-text 
data entry. Legal, governance and IT experts should be 
consulted from the outset, with data verification systems 
in place. A pilot registry would provide user feedback 
and facilitate registry improvement before national 
launch.
T8c: make it compulsory
The most effective way to maximise data completion 
would be by making the registry compulsory for clinician 
revalidation and for commissioning. Financial incentives 
could be applied to hospitals, and data completion rates 
could be published.
T8d: make it clearly useful
Making the registry useful for stakeholders for publica-
tions, audits, revalidation, implant procurement and 
policy development would increase ‘buy-in’ and data 
completion. Registry achievements should be dissemi-
nated to increase registry awareness.
PS Q9: Should patients be involved in the registry and if so how?
Patients should be involved in the registry in three 
different capacities.
T9a: leadership and development
A patient representative should be on the steering 
committee. This would help make the registry more 
accountable and meaningful.
T9b: accessing the registry
Patients should be given access to the registry, particularly 
to their own data. This would encourage data accuracy 
and completion. Safeguards would be needed to comply 
with data-protection and patient confidentiality.
T9c: entering data
It would be helpful and efficient for patients to enter 
their own data, particularly QoL data. However, data veri-
fication systems would be needed, and patient data entry 
would be complex and expensive; and should therefore be 
implemented once the registry is already well established.
PS Q10: Who should own the data of the registry?
T10a: independent national body
The registry should be owned by an independent national 
body such as: NHS England, DoH, the Secretary of State 
for Health and Public Health England. These bodies 
would provide longevity, impartiality, fair access and 
experience.
PS Q11: How should we fund the registry?
T11a: multiple sources
Funding should be requested from all stakeholder 
groups. Multiple income streams would provide financial 
security and increase engagement. Suggested funders 
included: ENT UK, DoH, patient charities, research 
grants, National Institute for Health Research, Medical 
Research Council, Action on Hearing Loss, healthcare 
providers, industry, The Ear Foundation, British Society 
of Audiology and The British Academy of Audiology.
T11b: levy on all implants used
A fee, applied to each implant used, would be a helpful 
source of income. The fee would be paid for by industry 
and the purchasing hospital.
PS Q12: Should we publish data on specific surgeons and 
hospitals?
T12a: wait until the registry is established
Potential benefits include: increased patient choice, trust, 
transparency and promoting a culture of learning. Nega-
tives include: data being misleading if unadjusted for case 
mix, data poorly reflecting that outcomes are dependent 
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on the entire healthcare team, reporting bias, risk-averse 
practices and reduced rates of data completion. Due to 
these risks, data should be reported once the registry is 
well established, with robust mechanisms for adjusted 
reporting.
PS Q13: Overall what do you think is the most important factor for 
making a registry successful?
T13a: data completeness
High levels of data completion and accuracy are essen-
tial. To achieve this, the most important factors include: 
involving stakeholders and patients during registry devel-
opment, compulsory data entry, making the registry 
useful for all groups and having robust data processing 
systems.
FGs with patients with hearing loss
All themes identified are presented below under each 
interview question. A summary of the extracted data 
giving rise each theme is provided. Table 3 summarises all 
themes identified.
FG Q1: What are your thoughts on developing a registry of patients 
that have surgically implanted hearing devices?
T1a: improve quality and safety of care
A registry would identify implant problems early, 
permit recall in the event of safety concerns and allow 
manufacturers to evaluate their products and improve 
effectiveness while encouraging competition. It would 
enable national comparison of outcomes and promote 
research.
T1b: help develop national guidelines and policy
A national registry would help develop guidance and 
policy that would reduce variation between centres. 
It would also help commissioners plan services better, 
including efficient implant procurement.
T1c: facilitate patient decision-making
By providing accurate information on implant effective-
ness, risks and new developments, a registry would help 
patients make decisions on their care.
T1d: challenges to registry development
Professionals may not input data, resulting in poor rates 
of data completion, and it would be challenging to reach 
agreement on the registry dataset and data ownership.
FG Q2: How do you think patients could be involved in developing, 
leading or managing such a registry?
T2a: formal patient representation
Patients should be formally involved in registry develop-
ment and leadership. This would make the registry more 
relevant and useful for patients.
FG Q3: What type of information do you think should be recorded 
in the registry?
T3a: registry dataset and easy-to-understand outcome measure
There should be a balance between comprehensibility 
and simplicity: comprehensive datasets would be too time 
consuming, while basic datasets would provide limited value. 
Table 5 summarises the data-items on which consensus was 
reached. The registry should include an outcome measure 
that is easily understandable by patients.
FG Q4: Would you want to be able to access and add information 
into the registry?
T4a: benefits of patient access
Patient access would make the registry more patient 
focused and help patients make decisions on their care.
T4b: patients entering data
Patients were keen to contribute to data entry via 
‘apps’. Paper-based entry could be used for patients not 
familiar with online platforms.
Table 5 Patient focus group suggested data-items
Preoperative Operative Postoperative
Patient demographics Name of hospital Levels of hearing
Occupation Grade of surgeon QoL
Comorbidities Date of surgery Complications
Preoperative QoL Indications for surgery Implant problems
Levels of hearing Name of implant Dates of follow-up appointments
Duration of hearing loss Implant serial number Details on assistive listening devices
Type of hearing loss Implant manufacturer Measure of cognitive status (for elderly 
patients)
Current hearing devices being used Duration of surgery Outcome measure understandable by 
patients
Information on previous hearing treatments Intraoperative complication(s)
Measure of cognitive status (for elderly 
patients)
QoL, quality of life.
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FG Q5: How can we help get patients to input their data and be 
involved in the registry?
T5a: make the registry useful for patients
Making the registry useful for patients would increase 
patient involvement. This could be achieved by having 
a patient section containing relevant information for 
patients.
T5b: make the registry simple and use technology
The registry should be simple and easy to use. This 
could be facilitated by using technology including 
‘apps’ and text message alerts to remind patients to 
enter data.
T5c: inbuilt patient discussion forum
A patient discussion forum within the registry would help 
engage patients. This forum would enable patients to 
learn from one another and share experiences.
FG Q6: Would you like the registry to contain information on results 
of named surgeons or hospitals?
T6a: inaccurate reflection of practices
Publishing this information may result in inaccurate 
reflection of practices. Surgeons with complex cases 
may have a higher risk of complications. Publication 
may result in surgeons becoming more risk-averse, and 
this data would not reflect that outcomes are depen-
dent on the entire healthcare team. An independent 
committee should have access to this data and provide 
feedback and support where necessary.
T6b: increase patient choice
This information would help increase patient choice 
and transparency and trust, while giving surgeons 
incentive to improve practices.
FG Q7: How do you think the data should be protected and kept 
confidential? Who should be allowed to access your data?
T7a: data governance
Data should be anonymous, with patients identifiable 
only via a patient number. Patient consent should be 
obtained for data collection, and registry access should 
be password protected.
T7b: data protection committee
The registry should have a committee for data protec-
tion, with a patient representative. All healthcare profes-
sionals should be able to access the registry if necessary 
for patient care.
FG Q8: Who should own the data of the registry?
T8a: independent organisation
The registry should be owned by an independent body. 
Registry ownership by a single hospital, academic group 
or implant company could lead to conflicts of interest, 
or data manipulation and therefore reduced confi-
dence in the registry.
FG Q9: Registries are expensive to set up and maintain. How 
should the registry be paid for?
T9a: multiple sources
Funding should be obtained from a mixture of sources, 
to avoid over-reliance on a single funder. All parties that 
benefit from the registry should contribute towards it. A fee 
should be charged for accessing registry data for research 
or industry purposes.
FG Q10: Overall, what do you think is the most important factor for 
making a registry successful?
T10a: data completeness
There was consensus among patients that the most 
important factor for registry success is high levels of data 
completion. To achieve this, patients and professional 
groups must be involved during the development and 
running of the registry.
Organisation of themes into a conceptual framework
The themes obtained from the interviews and FGs were 
mapped against a conceptual framework, consisting of 
five fundamental categories for successful registry devel-
opment22 (figure 1): (1) Planning includes setting registry 
objectives, appointing a steering committee, establishing 
registry management systems, acquiring long-term funding 
and defining registry ownership. (2) Registry governance 
involves appointing a data-protection committee and incor-
porating patient access and surgeon-specific data reporting 
once appropriate registry systems are in place. (3) Registry 
dataset includes selecting the fundamental data-items, 
having a free-text field, holding a dataset consensus meeting 
and implementing QoL data collection once the registry is 
well established. (4) Anticipating challenges consists of being 
aware of core challenges, including data completion and 
reaching consensus on registry dataset, resource require-
ments, data governance and legal factors. (5) Implementing 
solutions involves putting in place the following strategies to 
maximise registry success: compulsory data-input, advertise 
registry benefits, engage with influential groups, involve 
stakeholders and patients, make the registry user-friendly, 
have early input from legal, IT and governance experts.
DIsCussIOn
summary of findings
Figure 1 summarises the key requirements for developing 
a successful national registry of auditory implants.
relevance to existing research
The call for surgical registries extends beyond auditory 
implants, with a UK and Europe-wide drive to establish 
registries for all surgical implants.26 Across the EU and 
UK, new implants can enter surgical practice on the basis 
of similarity to an existing implant, rather than on the 
basis of its own clinical effectiveness.26 27 Concerns over 
the evidence base for surgical implants have been raised 
by several bodies including the IDEAL collaborative, the 
EU and the House of Commons Science and Technology 
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committee.26 27 Registries represent a pragmatic approach 
to address these concerns.28–33 Unlike conventional clin-
ical studies, registries can answer the fundamental ques-
tions required for policy and guideline development, 
namely: (1) Does it work? (2) Will it work here? (3) Is it 
worth it?34 Owing to these factors, the IDEAL collabora-
tive, the DoH, NICE, policy-makers and commissioning 
groups have called for surgical registries to improve our 
evidence base, drive quality and safety improvements, and 
inform policy and guidelines development.1 13 18 26 27
strengths and limitations
A key strength of this study is its inclusive and robust 
approach, involving multiple stakeholder groups and 
patients with hearing loss. Moreover, our findings built 
on a conceptual framework on successful surgical registry 
development, developed following our systematic review.22 
The approach enabled the collection of a rich dataset in 
a field where there is a paucity of empirical evidence and 
a high level of uncertainty. The interview schedules were 
informed by our published systematic literature review 
and were piloted before data collection. FGs and inter-
views were facilitated by individuals with expertise in qual-
itative interviewing, and patient and public involvement. 
Data were extracted and analysed by two independent 
data judges, with further verification by a data auditor. 
Participants were given an opportunity to discuss any 
other areas of registry development, not already covered 
by the questions and follow-ups.
Two limitations may restrict the generalisability of our 
findings. First, patients were selected from a UCL data-
base of patients, with FGs taking place at the UCL Ear 
Institute. This resulted in the majority of patients being 
located in or near London. Second, the use of purposive 
sampling for identifying PSs may have been prone to 
researcher bias. However, we attempted to mitigate this 
limitation by cross-checking the sample with independent 
experts from external institutions, and by giving all inter-
viewees the opportunity to suggest stakeholders for subse-
quent interviews.
Implications
This paper identifies the requirements for developing 
a successful national registry of auditory implants. Its 
approach and findings can be adopted on an interna-
tional level to inform successful registry development in 
other countries.
A successful registry of auditory implants would help 
develop robust national policy and guidelines. It would 
also help promote research and innovation, improve 
healthcare quality and safety and help patients make deci-
sions about their care. From a commissioning perspec-
tive, the registry would facilitate equitable access to care 
and efficient procurement of implants.
COnClusIOn
This study identifies the requirements for developing a 
successful national registry of auditory implants, bene-
fiting from the involvement of numerous PS groups and 
patients with hearing loss. Our approach may be used 
internationally to inform successful registry development.
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Figure 1 The key requirements for developing a successful national registry of auditory implants.
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